NYSE:CNMD CONMED - CNMD Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CONMED Co. Please log in to your account or sign up in order to add this asset to your watchlist. $102.61 -4.66 (-4.34%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range$101.50▼$111.1650-Day Range$79.75▼$107.2752-Week Range$71.09▼$155.51Volume1.21 million shsAverage Volume400,978 shsMarket Capitalization$3.13 billionP/E RatioN/ADividend Yield0.78%Price Target$120.00 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability CONMED MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside16.9% Upside$120.00 Price TargetShort InterestBearish11.71% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-0.74Upright™ Environmental ScoreNews Sentiment-0.14Based on 21 Articles This WeekInsider TradingSelling Shares$401,895 Sold Last QuarterProj. Earnings Growth24.40%From $3.32 to $4.13 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.03 out of 5 starsMedical Sector524th out of 1,028 stocksElectromedical Equipment Industry13th out of 24 stocks 2.5 Analyst's Opinion Consensus RatingCONMED has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $120.00, CONMED has a forecasted upside of 16.9% from its current price of $102.61.Amount of Analyst CoverageCONMED has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted11.71% of the outstanding shares of CONMED have been sold short.Short Interest Ratio / Days to CoverCONMED has a short interest ratio ("days to cover") of 8.5.Change versus previous monthShort interest in CONMED has recently decreased by 1.38%, indicating that investor sentiment is improving. Previous Next 0.8 Dividend Strength Dividend YieldCONMED has a dividend yield of 0.78%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCONMED does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, CONMED will have a dividend payout ratio of 19.37% next year. This indicates that CONMED will be able to sustain or increase its dividend. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreCONMED has received a 64.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Surgical instruments", "Medical technology engineering", and "Training for medical professionals" products. See details.Environmental SustainabilityThe Environmental Impact score for CONMED is -0.74. Previous Next 1.0 News and Social Media Coverage News SentimentCONMED has a news sentiment score of -0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 21 news articles for CONMED this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for CNMD on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CONMED insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $401,895.00 in company stock.Percentage Held by InsidersOnly 4.90% of the stock of CONMED is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for CONMED are expected to grow by 24.40% in the coming year, from $3.32 to $4.13 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CONMED is -36.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CONMED is -36.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioCONMED has a PEG Ratio of 2.95. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCONMED has a P/B Ratio of 3.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About CONMED (NYSE:CNMD) StockCONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States, Americas excluding the United States, Europe, Middle East, and Africa, and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.Read More Receive CNMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter. Email Address CNMD Stock News HeadlinesFebruary 5, 2023 | finance.yahoo.comCONMED Full Year 2022 Earnings: EPS Beats Expectations, Revenues LagFebruary 4, 2023 | finance.yahoo.comCONMED Corporation (NYSE:CNMD) Q4 2022 Earnings Call TranscriptFebruary 5, 2023 | Wall Street Watch Dogs (Ad)“Future Fuel” will unleash $11 trillion wave of wealthThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…February 4, 2023 | americanbankingnews.comContrasting CONMED (NYSE:CNMD) & BioLife Solutions (NASDAQ:BLFS)February 4, 2023 | americanbankingnews.comCONMED (NYSE:CNMD) versus TransMedics Group (NASDAQ:TMDX) Financial SurveyFebruary 3, 2023 | finance.yahoo.comCONMED (CNMD) Down on Q4 Earnings Miss, New System Hurts SalesFebruary 3, 2023 | americanbankingnews.comCONMED (NYSE:CNMD) Issues FY 2023 Earnings GuidanceFebruary 2, 2023 | apnews.comConmed: Q4 Earnings SnapshotFebruary 5, 2023 | Wall Street Watch Dogs (Ad)“Future Fuel” will unleash $11 trillion wave of wealthThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…February 2, 2023 | finance.yahoo.comCONMED Corporation Announces Fourth Quarter and Full-Year 2022 Financial ResultsFebruary 2, 2023 | finance.yahoo.comConmed (CNMD) Lags Q4 Earnings and Revenue EstimatesFebruary 1, 2023 | finance.yahoo.comMedTech Stocks' Earnings to Watch on Feb 2: BDX, DGX & CNMDJanuary 31, 2023 | americanbankingnews.comCONMED (CNMD) Set to Announce Quarterly Earnings on ThursdayJanuary 31, 2023 | americanbankingnews.comReviewing CONMED (NYSE:CNMD) & Star Equity (NASDAQ:STRR)January 9, 2023 | finance.yahoo.comCONMED Corporation to Announce Fourth Quarter 2022 Financial Results on February 2, 2023January 5, 2023 | finance.yahoo.comCONMED Corporation (CNMD) Stock Historical Prices & Data - Yahoo FinanceJanuary 4, 2023 | benzinga.comConmed Stock (NYSE:CNMD), Quotes and News SummaryDecember 17, 2022 | wsj.comCONMED Corp.December 9, 2022 | seekingalpha.comConMed: Still Fairly Priced, Turning More ConstructiveDecember 5, 2022 | finance.yahoo.comCONMED Corporation Announces Quarterly Cash DividendNovember 30, 2022 | finance.yahoo.comCONMED Corporation (NYSE:CNMD) Shares Could Be 27% Below Their Intrinsic Value EstimateNovember 25, 2022 | finance.yahoo.comWhy Is Conmed (CNMD) Up 6.8% Since Last Earnings Report?November 22, 2022 | finance.yahoo.comCONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare ConferenceNovember 15, 2022 | finance.yahoo.comCONMED Withdraws FY22 Guidance Due To Disruptions Associated With Software ImplementationNovember 15, 2022 | markets.businessinsider.comCONMED Corp. Withdraws Full-year GuidanceNovember 15, 2022 | finance.yahoo.comCONMED Corporation Withdraws 2022 Financial Outlook due to Temporary Impact from Software Implementation; Provides 2023 Financial OutlookNovember 14, 2022 | reuters.comCNMD.K - Conmed Corp | Stock Price & Latest News | ReutersSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CNMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter. Email Address CNMD Company Calendar Ex-Dividend for 1/5 Dividend12/15/2022Dividend Payable1/05/2023Last Earnings2/02/2023Today2/05/2023Next Earnings (Estimated)5/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNYSE:CNMD CUSIPN/A CIK816956 Webwww.conmed.com Phone(727) 392-6464Fax315-797-0321Employees3,800Year FoundedN/APrice Target and Rating Average Stock Price Forecast$120.00 High Stock Price Forecast$122.00 Low Stock Price Forecast$118.00 Forecasted Upside/Downside+16.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($2.84) Trailing P/E RatioN/A Forward P/E Ratio30.91 P/E Growth2.95Net Income$62.54 million Net Margins-7.71% Pretax Margin-2.87% Return on Equity11.47% Return on Assets4.06% Debt Debt-to-Equity Ratio1.45 Current Ratio2.75 Quick Ratio1.29 Sales & Book Value Annual Sales$1.05 billion Price / Sales2.99 Cash Flow$6.30 per share Price / Cash Flow16.30 Book Value$26.85 per share Price / Book3.82Miscellaneous Outstanding Shares30,480,000Free Float28,988,000Market Cap$3.13 billion OptionableOptionable Beta1.33 Key ExecutivesCurt R. HartmanChairman, President & Chief Executive OfficerTodd W. GarnerChief Financial Officer & Executive Vice PresidentShanna L. Cotti-OsmanskiChief Information Officer & Executive VP-ITHeather L. CohenEVP, Chief Human Resources & Legal OfficerTerence M. BergéVice President & ControllerKey CompetitorsInModeNASDAQ:INMDLivaNovaNASDAQ:LIVNTransMedics GroupNASDAQ:TMDXOutset MedicalNASDAQ:OMBioLife SolutionsNASDAQ:BLFSView All CompetitorsInsiders & InstitutionsFisher Asset Management LLCBought 42,227 shares on 2/3/2023Ownership: 1.127%Congress Wealth Management LLC DE Sold 2,970 shares on 2/2/2023Ownership: 0.097%SG Americas Securities LLCSold 3,980 shares on 2/2/2023Ownership: 0.030%ProShare Advisors LLCBought 595 shares on 2/2/2023Ownership: 0.015%Legacy Wealth Asset Management LLCSold 1,823 shares on 2/2/2023Ownership: 0.013%View All Insider TransactionsView All Institutional Transactions CNMD Stock - Frequently Asked Questions Should I buy or sell CONMED stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CNMD shares. View CNMD analyst ratings or view top-rated stocks. What is CONMED's stock price forecast for 2023? 2 Wall Street research analysts have issued 1-year target prices for CONMED's shares. Their CNMD share price forecasts range from $118.00 to $122.00. On average, they predict the company's share price to reach $120.00 in the next twelve months. This suggests a possible upside of 16.9% from the stock's current price. View analysts price targets for CNMD or view top-rated stocks among Wall Street analysts. How have CNMD shares performed in 2023? CONMED's stock was trading at $88.64 at the beginning of 2023. Since then, CNMD stock has increased by 15.8% and is now trading at $102.61. View the best growth stocks for 2023 here. When is CONMED's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023. View our CNMD earnings forecast. How were CONMED's earnings last quarter? CONMED Co. (NYSE:CNMD) released its earnings results on Thursday, February, 2nd. The company reported $0.42 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.93 by $0.51. The company earned $250.87 million during the quarter, compared to analysts' expectations of $302.48 million. CONMED had a positive trailing twelve-month return on equity of 11.47% and a negative net margin of 7.71%. The firm's revenue was down 8.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.07 EPS. How often does CONMED pay dividends? What is the dividend yield for CONMED? CONMED announced a quarterly dividend on Monday, December 5th. Investors of record on Friday, December 16th will be given a dividend of $0.20 per share on Thursday, January 5th. This represents a $0.80 dividend on an annualized basis and a yield of 0.78%. The ex-dividend date of this dividend is Thursday, December 15th. Read our dividend analysis for CNMD. Is CONMED a good dividend stock? CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.75%. Read our dividend analysis for CNMD. What guidance has CONMED issued on next quarter's earnings? CONMED issued an update on its first quarter 2023 earnings guidance on Friday, February, 3rd. The company provided earnings per share (EPS) guidance of $0.58-$0.63 for the period, compared to the consensus EPS estimate of $0.61. The company issued revenue guidance of $262.00 million-$272.00 million, compared to the consensus revenue estimate of $268.73 million. What is CONMED's stock symbol? CONMED trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNMD." Who are CONMED's major shareholders? CONMED's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Fisher Asset Management LLC (1.13%), New York State Common Retirement Fund (0.98%), Congress Asset Management Co. MA (0.55%), Mountain Pacific Investment Advisers Inc. ID (0.41%), Peregrine Capital Management LLC (0.38%) and Moody Aldrich Partners LLC (0.17%). View institutional ownership trends. How do I buy shares of CONMED? Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is CONMED's stock price today? One share of CNMD stock can currently be purchased for approximately $102.61. How much money does CONMED make? CONMED (NYSE:CNMD) has a market capitalization of $3.13 billion and generates $1.05 billion in revenue each year. The company earns $62.54 million in net income (profit) each year or ($2.84) on an earnings per share basis. How many employees does CONMED have? The company employs 3,800 workers across the globe. How can I contact CONMED? CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The official website for the company is www.conmed.com. The company can be reached via phone at (727) 392-6464 or via fax at 315-797-0321. This page (NYSE:CNMD) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.